ALS Drug Trial Stopped: No Benefits Found
A large and promising drug trial has been shut down after the results came back with negligible benefits. Biogen Idec was in stage III of the trial, and had seen “encouraging signs of efficacy” in the phase II of the trial. The drug was named dexpramipexole. The trial was composed on 943 patients in 11 countries, all […]
2 min read